论文部分内容阅读
目的探讨如何控制新药研发外包中可能出现的风险。方法主要分析了新药研发外包各阶段可能存在主要的风险及危害。结果与结论有针对性地采取风险控制措施:如建立科学的外包服务商选择评估体系;制定严谨、灵活的合作合同;建立利益共享、风险共担机制;建立有效的信息反馈、绩效测评机制等。都将有效实现对研发外包潜在风险的控制,使企业研发外包收益最大化。
Objective To explore how to control the risks that may appear in the R & D outsourcing of new drugs. The method mainly analyzes the main risks and harms that may exist in each phase of new drug R & D outsourcing. Results and Conclusion Targeted risk control measures are adopted: establishing a scientific outsourcing service provider selection and evaluation system, establishing a rigorous and flexible cooperation contract, establishing a mechanism for sharing benefits and risks, and establishing effective information feedback and performance evaluation mechanisms . Will effectively control the potential risk of R & D outsourcing and maximize the R & D outsourcing revenue of the enterprise.